Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
Guan Jiang, Ronghua Li, Chao Sun, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e111920-e111920
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 721
Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy
Sander Bekeschus
Redox Biology (2023) Vol. 65, pp. 102798-102798
Open Access | Times Cited: 42
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
Lu Si, Xiaoshi Zhang, Yongqian Shu, et al.
Translational Oncology (2019) Vol. 12, Iss. 6, pp. 828-835
Open Access | Times Cited: 115
Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs
Kateryna V. Laikova, Volodymyr V. Oberemok, Alisa M. Krasnodubets, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1516-1516
Open Access | Times Cited: 94
Melanoma therapeutics: a literature review
Pavan Kumar Dhanyamraju, Trupti Patel
Journal of Biomedical Research (2022) Vol. 36, Iss. 2, pp. 77-77
Open Access | Times Cited: 40
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Fei Du, Lu-han Yang, Jiao Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends
Benjamin Scaria, Siddhartha Sood, Christopher Raad, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8480-8480
Open Access | Times Cited: 39
Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma
Siddhartha Sood, Rahul Jayachandiran, Siyaram Pandey
Integrative Cancer Therapies (2021) Vol. 20
Open Access | Times Cited: 38
CDC25A inhibition sensitizes melanoma cells to doxorubicin and NK cell therapy
Xinyue Gao, Feichang Liu, Bo Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma
Sara Rhaissa Rezende do Reis, Edward Helal‐Neto, Aline Oliveira da Silva de Barros, et al.
Pharmaceutical Research (2021) Vol. 38, Iss. 2, pp. 335-346
Closed Access | Times Cited: 28
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity
Ritika Kurian, Hongbing Wang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 988-988
Open Access
Redox-sensitive TRP channels: a promising pharmacological target in chemotherapy-induced peripheral neuropathy
Ramandeep Singh, Pratik Adhya, Shyam Sunder Sharma
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 7, pp. 529-545
Closed Access | Times Cited: 24
Anticancer Triazenes: from Bioprecursors to Hybrid Molecules
Ana Paula Francisco, Eduarda Mendes, Ana Rita Santos, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 14, pp. 1623-1642
Closed Access | Times Cited: 28
Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice
Т. О. Кабилова, Aleksandra V. Sen’kova, В. П. Николин, et al.
PLoS ONE (2016) Vol. 11, Iss. 3, pp. e0150751-e0150751
Open Access | Times Cited: 26
Unveiling the Mechanisms Underlying the Immunotherapeutic Potential of Gene–miRNA and Drugs in Head and Neck Cancer
Danishuddin, Md Azizul Haque, Md. Zubbair Malik, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 921-921
Open Access | Times Cited: 2
Dacarbazine alone or associated with melanoma‐bearing cancer pain model induces painful hypersensitivity by TRPA1 activation in mice
Indiara Brusco, Simone Li Puma, Kelly Braga Chiepe, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 10, pp. 2797-2809
Open Access | Times Cited: 21
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
Michele Guida, Stefania Tommasi, Sabino Strippoli, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells
Diana Salvador, Verónica Bastos, Helena Oliveira
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3586-3586
Open Access | Times Cited: 9
Measuring Melanoma Nanomechanical Properties in Relation to Metastatic Ability and Anti-Cancer Drug Treatment Using Scanning Ion Conductance Microscopy
Emily Woodcock, Peter Gorelkin, Philip S. Goff, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2401-2401
Open Access | Times Cited: 5
Decoding the synergistic potential of MAZ‐51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals
Kganya Letsoalo, Evangeline Nortjé, Sean M. Patrick, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Open Access | Times Cited: 1
Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation
Luan F. Diniz, Paulo S. Carvalho, Mateus Araújo Castro e Souza, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3661-3673
Open Access | Times Cited: 1
DEVELOPMENT AND RESEARCH OF COMPOSITE MATERIALS WITH DACARBAZINE BASED ON POLYURETHANE-UREA WITH FRAGMENTS OF POLYVINYL ALCOHOL-POLYETHYLENE GLYCOL GRAFT COPOLYMER IN THE STRUCTURE
Tetiana Vislohuzova, R.A. Rozhnova, T.O. Kiselova, et al.
Polymer journal (2024) Vol. 46, Iss. 2, pp. 135-144
Closed Access | Times Cited: 1
Patient‐Derived Melanoma Immune‐Tumoroids as a Platform for Precise High throughput Drug Screening
Juliana Santos Rosa Viegas, Sofia Almeida Costa, Sofia Dias, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Evaluation of the Active Targeting of Melanin Granules after Intravenous Injection of Dendronized Nanoparticles
Catalina Bordeianu, Audrey Parat, S. Piant, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 2, pp. 536-547
Closed Access | Times Cited: 12
Melanoma-targeted delivery system (part 1): Design, synthesis and evaluation of releasable disulfide drug by glutathione
Radhia El Aissi, Jean‐Michel Chezal, Sébastien Tarrit, et al.
European Journal of Medicinal Chemistry (2015) Vol. 101, pp. 668-680
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top